Switching from Tramadol to Oxycodone

Introduction to Opioid Switching

The American Society of Clinical Oncology recommends opioid rotation when the current opioid fails to provide adequate analgesia despite dose escalation or causes unmanageable adverse effects 1, 2
The European Society for Medical Oncology suggests that opioid rotation should be part of a comprehensive assessment evaluating pain intensity, adverse effects, comorbidities, concomitant medications, and any pharmacokinetic factors that could limit drug effectiveness 1, 2

Always use lower doses than predicted by equianalgesic tables when switching opioids due to incomplete cross-tolerance between different opioid agents, as recommended by the National Comprehensive Cancer Network 3, 4, 1
Reduce the calculated oxycodone dose by 25-50% to account for incomplete cross-tolerance, according to the American Pain Society 3, 4

Calculate the total daily tramadol dose, including both scheduled and as-needed doses, as suggested by the Mayo Clinic 5, 6
Apply a conservative conversion approach, considering tramadol's dual mechanisms and the lack of an established equianalgesic ratio to morphine, as recommended by the European Association for Palliative Care 5, 7
For oral morphine to oral oxycodone, the established ratio is 1:1.5, meaning oxycodone is 1.5 times more potent than morphine, according to the American College of Physicians 1, 9

Be aware of the risk of serotonin syndrome when discontinuing tramadol, especially in patients taking SSRIs, SNRIs, TCAs, or MAOIs, as warned by the FDA 7, 8
Reduce the dose of tramadol in renal insufficiency and use caution when prescribing oxycodone in patients with renal or hepatic dysfunction, as recommended by the National Kidney Foundation 5

Evaluate pain intensity, functional status, and adverse effects at regular intervals (within 24-48 hours initially, then weekly during titration), as suggested by the Journal of the National Comprehensive Cancer Network 6, 1
Monitor for opioid-related adverse effects, including constipation, nausea, sedation, dizziness, and respiratory depression, as recommended by the Centers for Disease Control and Prevention 5, 7

In cancer pain management, opioid rotation to oxycodone is a well-established strategy when tramadol provides inadequate analgesia or causes intolerable side effects, according to the American Society of Clinical Oncology 3, 4, 1
For neuropathic pain, consider maintaining or adding first-line adjuvant medications (gabapentin, pregabalin, duloxetine, or nortriptyline) rather than relying solely on opioid escalation, as recommended by the International Association for the Study of Pain 5, 6